Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2884-2890

  Akimoto, Tetsuo ^a   Hunter, Nancy R ^a   Buchmiller, Lara ^a   Mason, Kathy ^a   Ang, K Kian ^a   Milas, Luka ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CANCER RADIOTHERAPY; CELLULAR DISTRIBUTION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

ANIMALS; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0032719534     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Salomon, D. S., Brandt, R., Ciardiello, R., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
2. Mendelsohn, J., and Fan, Z. Epidermal growth factor receptor family and chemosensitization. J. Natl. Cancer. Inst., 89: 341-343, 1997.
3. Iihara, K., Shiozaki, H., Tahara, H., Kobayashi, K., Inoue, M., Tamura, S., Myata, M., Oka, H., Doki, Y., and Mori, T. Prognostic significance of transforming growth factor-α in esophageal carcinoma. Implication for the autocrine proliferation. Cancer (Phila.), 71: 2902-2909, 1993.
4. Neal, D. E., Sharpies, L., Smith, K., Fennelly, J., Hall, R. R., and Harris, A. L. The epidermal growth factor and the prognosis of bladder cancer. Cancer (Phila.), 65: 1619-1625, 1990.
5. Klijin, J. G. M., Berns, P. M., Schmitz, P. I., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev., 13: 3-17, 1992.
6. Scambia, G., Benedetti-Panici, P., Battaglia, F., Ferrandina, G., Baiocchi, G., Greggi, S., De-Vincenzo, R., and Mancinso, S. Significance of epidermal growth factor receptor in advanced ovarian cancer. J. Clin. Oncol., 10: 529-535, 1992.
7. Dickstein, B. N., Wosikowski, K., and Bates, S. Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor. Mol. Cell. Endocrinol., 110: 205-211, 1995.
8. Hancock, M. C., Langton, B. C., Chan, T., Toy, P., Monahan, J. J., Mischak, R. P., and Shawver, L. K. A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. Cancer Res., 51: 4575-4580, 1991.
9. Pietras, R. J., Fendly, B. M., Chazin, V. R., Pegram, M. D., Howell, S. D., and Slamon, D. J. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene, 9: 1829-1838, 1994.
10. Baselga, J., Norton, L., Albanell, J., Kim, Y. M., and Mendelsohn, J. Recombinant humanized anti-HER2 antibody (Herceptin™) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res., 58: 2825-2831, 1998.
11. Ezekiel, M. P., Robert, F., Meredith, R. F., Spencer, S. A., Newsome, J., Khazaeli, M. B., Peters, G. E., Saleh, M., LoBuglio, A. F., and Waksal, H. W. Phase I study of anti-epidermal growth factor receptor (EGFR) antibody C225 in combination with irradiation in patients with advanced squamous cell carcinoma of the head and neck (SCCHN). Proc. Am. Assoc. Clin. Oncol., 17: 3952, 1998.
12. Kwok, T. T., and Sutherland, R. M. Differences in EGF related radiosensitization of human squamous carcinoma cells with high and low numbers of EGF receptors. Br. J. Cancer. 64: 251-254, 1991.
13. Kwok, T. T., and Sutherland, R. M. Cell cycle dependence of epidermal growth factor induced radiosensitization. Int. J. Radiat. Oncol. Biol. Phys., 22: 525-527, 1992.
14. Bonner, J. A., Maible, N. J., Folven, B. R., Christianson, T. J. H., and Spain, K. The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities. Int. J. Radiat. Oncol. Biol. Phys., 29: 243-247, 1994.
15. Wollman, R., Yahalom, J., Maxy, R., Pinto, J., and Fuks, Z. Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. Int. J. Radiat. Oncol. Biol. Phys., 30: 91-98, 1994.
16. Balaban, N., Moni, J., Shannon, M., Dang, L., Murphy, E., and Goldkorn, T. The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim. Biophys. Acta, 1314: 147-156, 1996.
17. Milas, L., Hunter, N., Mason, K. A., and Withers, H. R. Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res., 34: 61-71, 1974.
18. Milas, L., Wike, J., Hunter, N., Volpe, J., and Basic, I. Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res., 47: 1069-1075, 1987.
19. Suit, H., Allam, A., Allalunis-Turner, J., Brock, W., Girinsky, T., Hill, S., Hunter, N., Milas, L., Pearcey, R., Peters, L., Welch, D. R., West, C., and Efird, J. Is tumor cell radiation resistance correlated with metastatic ability? Cancer Res., 54: 1736-1741, 1994.
20. Milas, L., Hunter, N. R., Mason, K. A., Milross, C. G., Saito, Y., and Peters, L. J. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res., 55: 3564-3568, 1995.
21. Finney, D. J. Quantal response and the tolerance distribution. In: Statistical Methods in Biological Assay, pp. 454-456. London: Griffen, 1952.
22. Stephens, L. C., Ang, K. K., Schultheiss, T. E., Milas, L., and Meyn, R. E. Apoptosis in irradiated murine tumors. Radiat. Res., 127: 308-316, 1991.
23. Stephens, L. C., Hunter, N. R., Ang, K. K., Milas, L., and Meyn, R. E. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat. Res., 135: 75-80, 1993.
24. Meyn, R. E., Stephens, L. C., Ang, K. K., Hunter, N. R., Brock, W. A., Milas, L., and Peters, L. J. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int. J. Radiat. Biol., 64: 583-591, 1993.
25. Milas, L., Hunter, N., Basic, I., Volpe, J. P., and Tofilon, P. J. Effect of the radiosensitizer misonidazole and the radioprotector diethyldithiocarbamate on spontaneous metastasis formation of murine tumors. Int. J. Radiat. Oncol. Biol. Phys., 12: 1071-1074, 1986.
26. Schmidt-Ullrich, R. K., Valerie, K., Fogleman, P. B., and Walters, J. Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiat. Res., 145: 81-85, 1996.
27. Schmidt-Ullrich, R. K., Mikkelsen, R. B., Dent, P., Todd, D. G., Valerie, K., Kavanagh, B. D., Contessa, J. N., Rorrer, W. K., and Chen, P. B. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene, 15: 1191-1197, 1997.
28. Goldkorn, T., Balaban, N., Shannon, M., and Matsukuma, K. EGF receptor phosphorylation is affected by ionizing radiation. Biochim. Biophys. Acta, 1358: 289-299, 1997.
29. Kastan, M. B., Oneykwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
30. Kerr, J. F., Winterford, C. M., and Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy [published erratum appears in Cancer (Phila.)., 73: 3108, 1994]. Cancer (Phila.), 73: 2013-2026, 1994.
31. Korsmeyer, S. J., Shulter, J. R., Veis, D. J., Merry, D. E., and Oltvai, Z. N. Bcl-2/Bax: a homeostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol., 4: 327-332, 1993.
32. Raff, M. C. Social controls on cell survival and cell death. Nature (Lond.), 356: 397-400, 1992.
33. Adams, G. E., Hasan, N. M., and Joiner, M. C. Radiation, hypoxia and genetic stimulation: implications for future therapies. Radiother. Oncol., 44: 101-109, 1997.
34. Wikstrand, C. J., and Bigner, D. D. Prognostic applications of the epidermal growth factor receptor and its ligand, transforming growth factor-α. J. Natl. Cancer Inst., 90: 799-801, 1998.
35. Grandis, J. R., Melham, M. F., Gooding, W. E., Day, R., Hoist, V. A., Wagener, M. M., Drenning, S. D., and Tweardy, D. J. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst., 90: 824-832, 1998.
36. Pierce, J. H., Ruggiero, M., Fleming, T. P., Di-Fiore, P. P., Greenberger, J. S., Vanticovski, J., Schlessinger, J., Povera, G., and Aaronson, S. A. Signal transduction through EGF receptor transfected in IL-3-dependent hematopoietic cells. Science (Washington DC), 239: 628-631, 1988.
37. Sheridan, M. T., O'Dwyer, T., Seymour, C. B., and Mothersill, C. E. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiat. Oncol. Investig., 5: 180-186, 1997.
38. Lowe, S. W., Ruley, H. E., Jacks, T., and Houseman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74: 957-967, 1993.
39. Casey, G., Lo-Hsueh, M., Lopez, M. E., Vogelstein, B., and Stanbridge, E. J. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene, 6: 1791-1797, 1991.
40. Mueller, A., Odze, R., Jenkins, T. D., Shahsesfaei, A., Nakagawa, H., Inomoto, T., and Rustgi, A. K. A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res., 57: 5542-5549, 1997.
41. Rusch, V., Klimstra, D., Linkov, I., and Dmitrovsky, E. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res., 55: 1365-1372, 1995.
42. Levesque, M. A., Clark, G. M., Yu, H., and Diamandis, E. P. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators. Br. J. Cancer, 72: 720-727, 1995.
43. Iliakis, G. Cell cycle regulation in irradiated and nonirradiated cells. Semin. Oncol., 24: 602-615, 1997.
44. Carter, S., Auer, K. L., Reardon, D. B., Birrer, M., Fisher, P. B., Valerie, K., Schmidt-Ullrich, R., Mikkelsen, R., and Dent, P. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose radiation in A431 human squamous carcinoma cells. Oncogene, 16: 2787-2796, 1998.